Comment
doi: 10.1016/j.surg.2018.10.019.
Epub 2018 Nov 19.
Reply to: Insufficient number of examined lymph nodes may offset the survival benefit from neoadjuvant therapy in esophageal squamous cell carcinoma
Affiliations
- PMID: 30467040
- DOI: 10.1016/j.surg.2018.10.019
Item in Clipboard
Comment
Reply to: Insufficient number of examined lymph nodes may offset the survival benefit from neoadjuvant therapy in esophageal squamous cell carcinoma
Surgery.
2019 Mar.
No abstract available
Comment on
-
Timing of esophagectomy after neoadjuvant chemoradiation treatment in squamous cell carcinoma.Surgery. 2018 Sep;164(3):455-459. doi: 10.1016/j.surg.2018.04.026. Epub 2018 Jun 11. Surgery. 2018. PMID: 29903507
-
An insufficient number of examined lymph nodes may offset the survival benefit from neoadjuvant therapy in esophageal squamous cell carcinoma.Surgery. 2019 Mar;165(3):664-667. doi: 10.1016/j.surg.2018.07.022. Epub 2018 Sep 5. Surgery. 2019. PMID: 30193735 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
